Antigen presentation in immunity to murine malaria.

Rachel J Lundie1

  • 1Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, EH9 3JT, United Kingdom. rachel.lundie@ed.ac.uk

Summary

Developing a malaria vaccine requires understanding how cellular immunity starts during Plasmodium infection. Dendritic cells (DCs) prime T cells, influencing protection and disease, with Toll-like receptor (TLR) signaling playing a key role.